DK176595B1 - Stabiliseret oral farmaceutisk sammensætning indeholdende iodid og iodat samt fremgangsmåde til fremstilling heraf - Google Patents

Stabiliseret oral farmaceutisk sammensætning indeholdende iodid og iodat samt fremgangsmåde til fremstilling heraf Download PDF

Info

Publication number
DK176595B1
DK176595B1 DK200101258A DKPA200101258A DK176595B1 DK 176595 B1 DK176595 B1 DK 176595B1 DK 200101258 A DK200101258 A DK 200101258A DK PA200101258 A DKPA200101258 A DK PA200101258A DK 176595 B1 DK176595 B1 DK 176595B1
Authority
DK
Denmark
Prior art keywords
iodate
iodide
sodium
magnesium
phosphate
Prior art date
Application number
DK200101258A
Other languages
Danish (da)
English (en)
Inventor
Yongjun Duan
Kirk Dinehart
Jack Kessler
John Hickey
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of DK200101258A publication Critical patent/DK200101258A/da
Application granted granted Critical
Publication of DK176595B1 publication Critical patent/DK176595B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK200101258A 1999-02-26 2001-08-24 Stabiliseret oral farmaceutisk sammensætning indeholdende iodid og iodat samt fremgangsmåde til fremstilling heraf DK176595B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
US25806299 1999-02-26
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method
US0004411 2000-02-22

Publications (2)

Publication Number Publication Date
DK200101258A DK200101258A (da) 2001-10-26
DK176595B1 true DK176595B1 (da) 2008-10-20

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200101258A DK176595B1 (da) 1999-02-26 2001-08-24 Stabiliseret oral farmaceutisk sammensætning indeholdende iodid og iodat samt fremgangsmåde til fremstilling heraf

Country Status (19)

Country Link
US (1) US6248335B1 (sv)
JP (1) JP2002537341A (sv)
KR (1) KR100674324B1 (sv)
CN (1) CN1344163A (sv)
AT (1) AT413795B (sv)
AU (1) AU778774B2 (sv)
BR (1) BR0008509A (sv)
CA (1) CA2366679C (sv)
DE (1) DE10084290T1 (sv)
DK (1) DK176595B1 (sv)
ES (1) ES2226514B2 (sv)
FI (1) FI20011703A (sv)
GB (1) GB2364641B (sv)
IL (1) IL144955A (sv)
MX (1) MXPA01008550A (sv)
NO (1) NO20014101L (sv)
SE (1) SE0102843L (sv)
WO (1) WO2000050046A1 (sv)
ZA (1) ZA200106451B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) * 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
CA2627154C (en) * 2004-12-24 2010-12-21 Council Of Scientific And Industrial Research An improved iodized salt and a process for its preparation
JP4885877B2 (ja) 2005-01-10 2012-02-29 セクレタリー・デパートメント・オブ・アトミック・エナジー 被影響体のインビボ環境から放射性セシウム（＊Ｃｓ）、放射性ストロンチウム（＊Ｓｒ）、および放射性ヨウ素（＊Ｉ）を同時除染する予防混合物
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP2830627B1 (en) 2012-03-29 2024-05-01 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
WO2015080984A1 (en) 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
MX2016010328A (es) * 2014-02-10 2017-02-06 Hutchinson Fred Cancer Res Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
MX2019000902A (es) 2016-07-21 2020-09-03 I2Pure Corp Desinfectantes topicos emolientes.
TW201813648A (zh) * 2016-09-16 2018-04-16 美商愛歐根有限責任公司 口服分子碘組合物與方法
WO2019237065A1 (en) * 2018-06-08 2019-12-12 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
WO1999034809A1 (fr) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Preparations solides a base d'iodophore et procede de fabrication correspondant
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
CA2366679C (en) 2007-05-01
CN1344163A (zh) 2002-04-10
AU778774B2 (en) 2004-12-23
BR0008509A (pt) 2002-02-05
IL144955A0 (en) 2002-06-30
FI20011703A (sv) 2001-10-16
GB2364641B (en) 2004-06-30
GB0122808D0 (en) 2001-11-14
ATA90122000A (de) 2005-10-15
ES2226514A1 (es) 2005-03-16
WO2000050046A8 (en) 2003-11-27
SE0102843L (sv) 2001-10-26
IL144955A (en) 2006-12-31
ZA200106451B (en) 2002-08-06
CA2366679A1 (en) 2000-08-31
KR20010103014A (ko) 2001-11-17
SE0102843D0 (sv) 2001-08-27
US6248335B1 (en) 2001-06-19
WO2000050046A1 (en) 2000-08-31
MXPA01008550A (es) 2003-08-19
ES2226514B2 (es) 2007-02-16
NO20014101L (no) 2001-10-12
AU3371300A (en) 2000-09-14
DE10084290T1 (de) 2003-04-03
AT413795B (de) 2006-06-15
NO20014101D0 (no) 2001-08-23
DK200101258A (da) 2001-10-26
FI20011703A0 (sv) 2001-08-24
KR100674324B1 (ko) 2007-01-24
GB2364641A (en) 2002-02-06
JP2002537341A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
DK176595B1 (da) Stabiliseret oral farmaceutisk sammensætning indeholdende iodid og iodat samt fremgangsmåde til fremstilling heraf
FI94214B (sv) Förfarande för framställning av en farmaceutisk tablett och ett farmaceutiskt granulat
CA2301185C (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
KR100412219B1 (ko) 분자 요오드의 경구투여용 제약 조성물
EA011275B1 (ru) Суточная дозированная единица комплекса этинилэстрадиол-циклодекстрин
KR20040058360A (ko) 합성 감미료
JP5283632B2 (ja) ベンズイミダゾール−７−カルボキシレート誘導体およびｐＨ調整剤を含有する固形医薬組成物
CZ316594A3 (en) Stomach protecting stable omeprazole preparations having the form of micro-capsules and process for preparing thereof
NZ239753A (en) Dry granulated composition comprising water soluble salt of a basic compound and a water-soluble alkaline stabiliser
ZA200510224B (en) Pharmaceutical formulation comprising levothyroxine sodium
NZ242271A (en) Medicaments containing a vitamin d compound stabilised by a basic substance
KR101849125B1 (ko) 프로톤 펌프 저해제를 포함하는 고체 분산체, 이의 제조방법 및 이를 포함하는 구강 붕해정
JP2809971B2 (ja) 血液透析用製剤
JP6367042B2 (ja) ボリコナゾールを含む医薬組成物
JP4999297B2 (ja) 高含量塩酸テルビナフィン小型錠剤
AU2004234176B2 (en) Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
GB2395901A (en) Stabilised tablets containing iodide and iodate
JP2564822B2 (ja) 塩酸ブロムヘキシン固形製剤
JP3895757B1 (ja) 粉末状組成物
EP3982935A1 (en) Composition comprising metformin hci, vitamin b12 and at least one flow additive
TW202227047A (zh) 甲狀腺荷爾蒙的製劑化方法
WO2020254396A1 (en) Solid pharmaceutical dosage form comprising spray dried vitamin b12
KR20230124504A (ko) 라베프라졸 및 탄산수소나트륨을 포함하는 약학적 조성물
UA77626C2 (en) Compositions comprising complexes of estrogen and cyclodextrin
KR19990077172A (ko) β-락탐 항생물질 함유 정제 및 그의 제조 방법

Legal Events

Date Code Title Description
PBP Patent lapsed

Ref document number: DK